Insulet | PODD - Loan Capital

Stock Price
241.70
Daily Change
-1.45 -0.60%
Monthly
-19.21%
Yearly
-14.62%
Q1 Forecast
247.93

Insulet reported $934.9M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 11.6B 1.33B Sep/2025
Align Technology USD 0 0 Dec/2024
AtriCure USD 61.86M 0 Sep/2025
Avanos Medical USD 93.4M 2.3M Sep/2025
Baxter International USD 9.49B 80M Jun/2025
Becton, Dickinson and Co. USD 17.62B 90M Sep/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cardinal Health USD 8.35B 633M Dec/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Dexcom USD 1.29B 55.6M Sep/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Globus Medical USD 173K 84K Jun/2025
ICU Medical USD 1.31B 23.8M Sep/2025
Insulet USD 934.9M 4.1M Sep/2025
Integra LifeSciences USD 1.79B 565.41M Sep/2025
J&J USD 39.41B 173M Sep/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 26.18B 537M Jun/2025
Merit Medical Systems USD 732.92M 1.12M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Solventum Corp USD 5.14B 2.68B Sep/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 309.59M 444K Sep/2025
Teleflex USD 2.57B 769.86M Sep/2025
West Pharmaceutical Services USD 202.7M 100K Sep/2025
Zimmer Biomet Holdings USD 7.51B 760.1M Sep/2025